🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Understanding How Movements Are Transferred From Task to Task in Parkinson's Disease

RecruitingNAAges 50 Years - anyAllMcGill University
NCT07351032 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to understand how a specific brain area, the Posterior Parietal Cortex (PPC), plays a role in movement transfer from walking on a split-belt treadmill (SBT) to walking on the ground in people with Parkinson's disease (PwPD). Here, investigators will apply repeated transcranial magnetic stimulation (rTMS) to upregulate the PPC. Then, the differences in the gait parameters between pre- and post-interventions will be compared between the TMS-active and the TMS-sham.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * a confirmed diagnosis of idiopathic Parkinson's disease * absence of freezing of gait confirmed by a "No" answer to the second item of the New Freezing of Gait Questionnaire (NFOGQ) and no observation of FOG during a freezing provoking test * no other neurological diagnosis * no severe musculoskeletal/orthopedic or vestibular condition that interferes with walking and or significantly affects balance * no mild cognitive impairment (Montreal Cognitive Assessment ≥ 25) * able to walk independently and without assistive device for 30 minutes * no previous experience with split-belt treadmill. Exclusion Criteria: * severe dyskinesia that interacts with walking and balance hearing or visual impairment * observed inability to walk safely on a tied-belt treadmill * neurological disorders other than PD or other pathology (e.g., orthopedic) interfering with mobility. - contradiction for TMS * implanted deep brain stimulator.
💊

What it tests

  • Transcranial Magnetic Stimulation Active
  • Transcranial Magnetic Stimulation Sham
📍

Where

1 site
McGill University - Currie Gymnasium
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy